About Us
At BridgePoint Life Sciences, we believe exceptional patient care begins with smarter commercialization strategies. Founded by former hospital leaders and market access experts, we bring a unique blend of clinical insight and industry know-how that few firms can match. This foundation allows us to help biopharma clients not just launch therapies but ensure they reach the patients who need them most, faster.
Our team has been at the forefront of some of the industry’s most complex challenges, including:
Pioneering Value-Based Agreements (VBAs): We negotiated the first-ever U.S. VBA for a therapy and have since structured groundbreaking agreements for CAR-T and gene therapies expertise that is truly one-of-a-kind in the industry.
Rare & Specialty Disease Focus: From neurology and oncology to cardiopulmonary, diabetes, anti-infectives, CAR-T, and gene therapies, our launch experience spans the full spectrum of therapeutic areas where speed to adoption is most critical.
Integrated Access Strategy: We are uniquely positioned to bridge payers, providers, and policymakers, aligning incentives and creating solutions that are clinically sound, financially viable, and operationally executable.
Deep Hospital & IDN Expertise: With extensive experience inside major health systems, we understand formulary pathways, 340B impact, inpatient and outpatient reimbursement, and the growing role of in-hospital specialty pharmacies.
Our Approach
Every engagement is shaped by our patient-first values. We design access strategies that work in the real world, balancing the needs of patients, providers, and payers. By leveraging our proprietary datasets, hospital economics expertise, and extensive payer network connections, we deliver insights that enable precision-targeted access strategies accelerating uptake while reducing barriers.
Our Impact
We’ve successfully:
Build launch strategies for rare and specialty products, from end-to-end planning through execution.
Optimize payer and market access while minimizing rebate pressure through value-based and outcomes-driven models.
Navigate hospital onboarding of complex therapies and formulary approvals to enable early adoption.
Design channel and distribution models that ensure therapies reach patients smoothly and sustainably.
At BridgePoint Life Sciences, our strength lies in turning complexity into clarity. We don’t just advise we partner with you to deliver strategies that make innovative therapies accessible, adopted, and impactful for the patients who need them most.